PMC:7275137 / 9657-9859
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7275137","sourcedb":"PMC","sourceid":"7275137","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7275137","text":"nes; from a pharmacological point of view, these compounds are often described by very large volumes of distribution and long residual effects [18]. Moreover, lysosomotropic agents inhibit endosomal mat","tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T47","span":{"begin":189,"end":198},"obj":"Body_part"}],"attributes":[{"id":"A47","pred":"fma_id","subj":"T47","obj":"http://purl.org/sig/ont/fma/fma67180"},{"subj":"T47","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T58","span":{"begin":10,"end":11},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T59","span":{"begin":144,"end":146},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"attributes":[{"subj":"T58","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T59","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"2_test","denotations":[{"id":"32522674-22198553-48147843","span":{"begin":144,"end":146},"obj":"22198553"},{"id":"T22782","span":{"begin":144,"end":146},"obj":"22198553"}],"attributes":[{"subj":"32522674-22198553-48147843","pred":"source","obj":"2_test"},{"subj":"T22782","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#ec93d6","default":true},{"id":"LitCovid-PD-CLO","color":"#93ece8"},{"id":"2_test","color":"#ecce93"}]}]}}